Production of L-carnitine by secondary metabolism of bacteria

Author:

Bernal Vicente,Sevilla Ángel,Cánovas Manuel,Iborra José L

Abstract

Abstract The increasing commercial demand for L-carnitine has led to a multiplication of efforts to improve its production with bacteria. The use of different cell environments, such as growing, resting, permeabilized, dried, osmotically stressed, freely suspended and immobilized cells, to maintain enzymes sufficiently active for L-carnitine production is discussed in the text. The different cell states of enterobacteria, such as Escherichia coli and Proteus sp., which can be used to produce L-carnitine from crotonobetaine or D-carnitine as substrate, are analyzed. Moreover, the combined application of both bioprocess and metabolic engineering has allowed a deeper understanding of the main factors controlling the production process, such as energy depletion and the alteration of the acetyl-CoA/CoA ratio which are coupled to the end of the biotransformation. Furthermore, the profiles of key central metabolic activities such as the TCA cycle, the glyoxylate shunt and the acetate metabolism are seen to be closely interrelated and affect the biotransformation efficiency. Although genetically modified strains have been obtained, new strain improvement strategies are still needed, especially in Escherichia coli as a model organism for molecular biology studies. This review aims to summarize and update the state of the art in L-carnitine production using E. coli and Proteus sp, emphasizing the importance of proper reactor design and operation strategies, together with metabolic engineering aspects and the need for feed-back between wet and in silico work to optimize this biotransformation.

Publisher

Springer Science and Business Media LLC

Subject

Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Reference108 articles.

1. Löster H: Carnitine and cardiovascular diseases. 2003, Bochum: Ponte Press Verlags GmbH

2. Naidu GSN, Lee IY, Lee EG, Kang GH, Park YH: Microbial and enzymatic production of L-carnitine. Bioprocess Eng. 2000, 23: 627-635. 10.1007/s004490000212.

3. Seim H, Eichler K, Kleber HP: L-carnitine and its precursor, γ-butyrobetaine. Nutraceuticals in Health and Disease Prevention. Edited by: Kramer K, Hoppe PP, Packer L. 2001, New York: Marcel Dekker, Inc, 217-256.

4. Kleber HP: Bacterial carnitine metabolism. FEMS Microbiol Lett. 1997, 147: 1-9. 10.1111/j.1574-6968.1997.tb10212.x.

5. Jung H, Jung K, Kleber HP: L(-)-carnitine uptake by Escherichia coli. J Basic Microbiol. 1990, 30: 507-514. 10.1002/jobm.3620300711.

Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3